期刊文献+

银杏内酯吸入剂对哮喘模型豚鼠气管嗜酸性粒细胞浸润的影响 被引量:3

Effects of Ginkgolides Inhalation on Eosinophils Infiltration in Airway of Asthmatic Guinea Pig Model
原文传递
导出
摘要 目的:探讨银杏内酯吸入剂对哮喘模型豚鼠气道嗜酸性粒细胞浸润的影响。方法:将豚鼠随机分为7组,每组8只,分别为哮喘模型组,银杏内酯吸入剂低、中、高剂量组(剂量分别为5、10、20mg·kg-1),银杏内酯腹腔注射(ip)组(剂量为20mg·kg-1),地塞米松组(剂量为10mg·kg-1)和正常对照组,计数肺灌注液(BALF)和支气管中的嗜酸性粒细胞(EOS)数。结果:与正常对照组比较,模型组BALF中的EOS显著增多,银杏内酯吸入剂组可显著减少BALF和支气管中的EOS浸润数(P<0.05)。结论:银杏内酯吸入剂能对抗哮喘豚鼠气道嗜酸性粒细胞浸润,可作为治疗支气管哮喘的一种新方法。 OBJECTIVE: To observe the effects of Ginkgolides inhalation on eosinophils infiltration in airway of asthmatic guinea pig model. METHODS: Guinea pigs were divided into seven groups(n = 8 in each group): model group, ginkgolides inhalation low, medium and high dosage groups(5, 10, 20mg·kg^-1, respectively), ginkgolides ip group (at a dosage of 20 mg·kg^-1), Dexamethasone ip group (at a dosage of 10 mg·kg^-1), normal control group. The eosinophils (EOS) in bronchoalveotar lavage fluid (BALF) and trachea were counted. RESULTS: As compared with normal control group, the number of EOS in BALF was significantly increased in model group, but that in BALF and trachea of the Ginkgolides inhalation group was significantly reduced(P〈0.05) .CONCLUSION: Ginkgolides inhalation can antagonize the infiltration of eosinophils in airway of asthmatic guinea pigs, and it can be used as a new therapy for bronchial asthma.
出处 《中国药房》 CAS CSCD 北大核心 2007年第15期1132-1133,共2页 China Pharmacy
关键词 银杏内酯 吸入剂 支气管哮喘 嗜酸性粒细胞 Ginkgolides Inhalation Bronchial asthma Eosinophils
  • 相关文献

参考文献7

二级参考文献33

  • 1胡素贤,黄瑾.实验性哮喘小鼠T淋巴细胞对B细胞分泌特异性IgE的调节作用[J].吉林大学学报(医学版),2004,30(4):515-517. 被引量:4
  • 2董竞成,倪健,宫兆华.中药单体复方防治支气管哮喘的实验研究[J].中国中西医结合杂志,2004,24(8):717-721. 被引量:6
  • 3Stelmach I,Gorski P,Jerzynska J,et al.A randomized,double-blind trial of the effect of treatment with formoterol on clinical and inflammatory parameters of asthma in children [J].Ann Allergy Asthma Immunol,2002,89:67-73.
  • 4Jeffery P K,Venge P,Gizycki M J,et al.Effects of salmeterol on mucosal inflammation in asthma:a placebo-controlled study [J].Eur Respir J,2002,20:1378-1385.
  • 5Zarkovic J P,Marenk M,Valovirta E,et al.One-year safety study with bambuterol once daily and terbutaline three times daily in 2-12-year-old children with asthma [J].Pediatr Pulmonol,2000,29:424-429.
  • 6Gartner I.Separation of human eosinophils in density gradients of polyvinylpyrrolidone-coated silica gel (percoll) [J].Immunol,1980,40:133-136.
  • 7Erpenbeck V J,Hohlfeld J M,Petschallies J,et al.Local release of eosinophil peroxidase following segmental allergen provocation in asthma [J].Clin Exp Allergy,2003,33:331-336.
  • 8Caulfield J P,Hein A,Rothenberg M E,et al.A morphometric study of normodense and hypodense human eosinophils that are derived in vivo and in vitro [J].Am J Pathol,1990,137:27-41.
  • 9Lamkhioued B,Renzi P M,Abi-Younes S,et al.Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation [J].J Immunol,1997,159:4593-4601.
  • 10Mattoli S,Stacey M A,Sun G,et al.Eotaxin expression and eosinophilic inflammation in asthma [J].Biochem Biophys Res Commun,1997,236:299-301.

共引文献22

同被引文献44

引证文献3

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部